These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 9422395

  • 1. Chronic blockade of CD28-B7-mediated T-cell costimulation by CTLA4Ig reduces intimal thickening in MHC class I and II incompatible mouse heart allografts.
    Glysing-Jensen T, Räisänen-Sokolowski A, Sayegh MH, Russell ME.
    Transplantation; 1997 Dec 27; 64(12):1641-5. PubMed ID: 9422395
    [Abstract] [Full Text] [Related]

  • 2. CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis.
    Kim KS, Denton MD, Chandraker A, Knoflach A, Milord R, Waaga AM, Turka LA, Russell ME, Peach R, Sayegh MH.
    Am J Pathol; 2001 Mar 27; 158(3):977-86. PubMed ID: 11238045
    [Abstract] [Full Text] [Related]

  • 3. Long-term survival of rat to mouse cardiac xenografts with prolonged blockade of CD28-B7 interaction combined with peritransplant T-cell depletion.
    Rehman A, Tu Y, Arima T, Linsley PS, Flye MW.
    Surgery; 1996 Aug 27; 120(2):205-12. PubMed ID: 8751584
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.
    Sayegh MH, Akalin E, Hancock WW, Russell ME, Carpenter CB, Linsley PS, Turka LA.
    J Exp Med; 1995 May 01; 181(5):1869-74. PubMed ID: 7536798
    [Abstract] [Full Text] [Related]

  • 6. CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipients.
    Stadlbauer TH, Schaub M, Korom S, Onodera K, Sayegh MH, Kupiec-Weglinski JW.
    Transplantation; 1997 Dec 27; 64(12):1816-22. PubMed ID: 9422425
    [Abstract] [Full Text] [Related]

  • 7. The effect of CD28/B7 blockade on alloreactive T and B cells after liver cell transplantation.
    Reddy B, Gupta S, Chuzhin Y, Kalergis AM, Budhai L, Zhang M, Droguett G, Horwitz MS, Chowdhury JR, Nathenson SG, Davidson A.
    Transplantation; 2001 Mar 27; 71(6):801-11. PubMed ID: 11330546
    [Abstract] [Full Text] [Related]

  • 8. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors.
    Li W, Lu L, Wang Z, Wang L, Fung JJ, Thomson AW, Qian S.
    Transplantation; 2001 Oct 27; 72(8):1423-32. PubMed ID: 11685115
    [Abstract] [Full Text] [Related]

  • 9. Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis.
    Russell ME, Hancock WW, Akalin E, Wallace AF, Glysing-Jensen T, Willett TA, Sayegh MH.
    J Clin Invest; 1996 Feb 01; 97(3):833-8. PubMed ID: 8609241
    [Abstract] [Full Text] [Related]

  • 10. Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients.
    Sayegh MH, Zheng XG, Magee C, Hancock WW, Turka LA.
    Transplantation; 1997 Dec 27; 64(12):1646-50. PubMed ID: 9422396
    [Abstract] [Full Text] [Related]

  • 11. T-cell costimulatory blockade in experimental chronic cardiac allograft rejection: effects of cyclosporine and donor antigen.
    Chandraker A, Russell ME, Glysing-Jensen T, Willett TA, Sayegh MH.
    Transplantation; 1997 Apr 27; 63(8):1053-8. PubMed ID: 9133464
    [Abstract] [Full Text] [Related]

  • 12. CD28 blockade alters cytokine mRNA profiles in cardiac transplantation.
    Lin H, Wei RQ, Goodman RE, Bolling SF.
    Surgery; 1997 Aug 27; 122(2):129-37. PubMed ID: 9288115
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. CD28-independent costimulation of T cells in alloimmune responses.
    Yamada A, Kishimoto K, Dong VM, Sho M, Salama AD, Anosova NG, Benichou G, Mandelbrot DA, Sharpe AH, Turka LA, Auchincloss H, Sayegh MH.
    J Immunol; 2001 Jul 01; 167(1):140-6. PubMed ID: 11418642
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo.
    Akalin E, Chandraker A, Russell ME, Turka LA, Hancock WW, Sayegh MH.
    Transplantation; 1996 Dec 27; 62(12):1942-5. PubMed ID: 8990393
    [Abstract] [Full Text] [Related]

  • 18. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression.
    Guillot C, Mathieu P, Coathalem H, Le Mauff B, Castro MG, Tesson L, Usal C, Laumonier T, Brouard S, Soulillou JP, Lowenstein PR, Cuturi MC, Anegon I.
    J Immunol; 2000 May 15; 164(10):5258-68. PubMed ID: 10799887
    [Abstract] [Full Text] [Related]

  • 19. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD.
    Via CS, Rus V, Nguyen P, Linsley P, Gause WC.
    J Immunol; 1996 Nov 01; 157(9):4258-67. PubMed ID: 8892665
    [Abstract] [Full Text] [Related]

  • 20. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion.
    Lin H, Bolling SF, Linsley PS, Wei RQ, Gordon D, Thompson CB, Turka LA.
    J Exp Med; 1993 Nov 01; 178(5):1801-6. PubMed ID: 8228826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.